(Q37817000)

English

Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial? (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

phase III clinical trial

0 references

chemoradiotherapy

0 references

4

object named as

Rainer Fietkau

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

object named as

Claus Rödel

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

Dirk Arnold

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Heinz Becker

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Michael Ghadimi

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Ullrich Graeven

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Clemens Hess

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Ralf Hofheinz

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Werner Hohenberger

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Stefan Post

10

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Rudolf Raab

11

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Rolf Sauer

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Frederick Wenz

13

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Torsten Liersch

14

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

30 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

186

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

658-664

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Molecular targeted treatment and radiation therapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Integration of novel agents into combined-modality treatment for rectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2194-2

21 January 2018

[The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality therapy for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21136027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-010-2194-2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37817000&oldid=2200979501"